About Us |
|
|
Transforming the Surface of Medical Devices
Controlling the body’s reaction to medical materials is a difficult problem for medical device manufacturers. Most solutions, including coatings, polymers and traditional surface treatments fail to deliver the needed performance. In fact, many complicate the problem.
Chameleon solves these problems by atomically engineering medical device surfaces to impart the needed capabilities. With its Molecular Surface ModificationSM technologies, Chameleon not only controls adverse reactions, but delivers a whole new range of therapeutic options:
- Creates tunable anti-microbial surfaces to battle bacteria
- Delivers bone, gum, endothelial, fibroblast and other cell attachment to medical devices
- Prevents or reduces cell attachment to implanted devices
- Attaches and delivers proteins, peptides, growth factors, enzymes and other biological compounds to surfaces
- Provides drug eluting surfaces without the complications of coatings, particularly the disadvantages of polymer coatings
- Makes devices radiopaque without altering underlying performance
- Controls surface hardness and lubricity
Creating an Extensive Intellectual Property Base
Chameleon has built and continues to add to a rich IP portfolio of patents and trade secrets.
Quality Certification
Chameleon has achieved ISO 13485 certification to provide a highest level of quality support for its customers.
Experienced Medical Industry and Scientific Team
Located in Minneapolis, Minnesota, Chameleon is lead by management experienced in the medical device industry and is supported by a development team with broad and deep background in atomic and molecular physics plus experience in organic chemistry, microbiology and bioengineering. This unique experience base allows Chameleon to translate its capabilities into high-value performance surfaces for medical device manufacturers.
|
|
